Witzke O - Search Results

1

[Quality of life following transplantation. The impact ofa new immunosuppressive substance].

Lütkes P, Franke G, Witzke O, Zimmermann U, Kohnle M, Philipp T, Heemann U. Lütkes P, et al. Among authors: witzke o. Zentralbl Chir. 1999;124(2):90-4. Zentralbl Chir. 1999. PMID: 10209841 German.

2

Diltiazem minimizes tubular damage due to FK506-mediated nephrotoxicity following ischemia and reperfusion in rats.

Becker G, Witzke O, Baltes A, Hamar P, Philipp T, Heemann U. Becker G, et al. Among authors: witzke o. Transpl Immunol. 1996 Mar;4(1):68-71. doi: 10.1016/s0966-3274(96)80040-2. Transpl Immunol. 1996. PMID: 8762016

3

Tacrolimus (FK 506) therapy in simultaneous pancreas kidney transplantation.

Becker G, Witzke O, Friedrich J, Wagner K, Heemann U, Philipp T. Becker G, et al. Among authors: witzke o. Transplant Proc. 1996 Dec;28(6):3169-70. Transplant Proc. 1996. PMID: 8962228 No abstract available.

4

Rescue therapy with tacrolimus in simultaneous pancreas/kidney transplantation.

Becker G, Witzke O, Friedrich J, Albrecht KH, Wagner K, Philipp T, Heemann U. Becker G, et al. Among authors: witzke o. Transpl Int. 1997;10(1):51-4. doi: 10.1007/BF02044342. Transpl Int. 1997. PMID: 9002152

5

Beta-human choriogonadotropin therapy and HIV-related Kaposi's sarcoma.

Witzke O, Hense J, Reinhardt W, Reiner C, Hoermann R, Philipp T. Witzke O, et al. Eur J Med Res. 1997 Apr 21;2(4):155-8. Eur J Med Res. 1997. PMID: 9110921 Clinical Trial.

6

Kidney transplantation improves quality of life.

Witzke O, Becker G, Franke G, Binek M, Philipp T, Heemann U. Witzke O, et al. Transplant Proc. 1997 Feb-Mar;29(1-2):1569-70. doi: 10.1016/s0041-1345(96)00678-1. Transplant Proc. 1997. PMID: 9123428 No abstract available.

7

Side-effects of ritonavir and its combination with saquinavir with special regard to renal function.

Witzke O, Plentz A, Schäfers RF, Reinhardt W, Heemann U, Philipp T. Witzke O, et al. AIDS. 1997 May;11(6):836-8. AIDS. 1997. PMID: 9143629 No abstract available.

8

A comparison of EMIT and FPIA methods for the detection of cyclosporin A blood levels: does impaired liver function make a difference?

Witzke O, Heemann U, Thesing A, Wolfhard U, Erhard J, Philipp T, Michel MC. Witzke O, et al. Eur J Clin Pharmacol. 1997;52(5):413-6. doi: 10.1007/s002280050311. Eur J Clin Pharmacol. 1997. PMID: 9272414

9

Metabolic factors have a major impact on kidney allograft survival.

Hamar P, Müller V, Kohnle M, Witzke O, Albrecht KH, Philipp T, Heemann U. Hamar P, et al. Among authors: witzke o. Transplantation. 1997 Oct 27;64(8):1135-9. doi: 10.1097/00007890-199710270-00009. Transplantation. 1997. PMID: 9355829

10

Tacrolimus rescue therapy in patients with rejection and long-term dialysis after kidney transplantation.

Witzke O, Becker G, Erhard J, Lütkes P, Szabo A, Philipp T, Heemann U. Witzke O, et al. Clin Nephrol. 1998 Jan;49(1):24-7. Clin Nephrol. 1998. PMID: 9491282

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

390 results

Search Page

Filters